chr1-234609329-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_182972.3(IRF2BP2):c.166G>A(p.Ala56Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000262 in 1,524,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A56A) has been classified as Likely benign.
Frequency
Consequence
NM_182972.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF2BP2 | NM_182972.3 | c.166G>A | p.Ala56Thr | missense_variant | 1/2 | ENST00000366609.4 | NP_892017.2 | |
IRF2BP2 | NM_001077397.1 | c.166G>A | p.Ala56Thr | missense_variant | 1/2 | NP_001070865.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF2BP2 | ENST00000366609.4 | c.166G>A | p.Ala56Thr | missense_variant | 1/2 | 1 | NM_182972.3 | ENSP00000355568.3 | ||
IRF2BP2 | ENST00000366610.7 | c.166G>A | p.Ala56Thr | missense_variant | 1/2 | 1 | ENSP00000355569.3 | |||
ENSG00000228830 | ENST00000436039.1 | n.631-92C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151430Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.00000219 AC: 3AN: 1372986Hom.: 0 Cov.: 34 AF XY: 0.00000294 AC XY: 2AN XY: 679642
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151430Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 73938
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with IRF2BP2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 56 of the IRF2BP2 protein (p.Ala56Thr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at